Physician Assistant · San Jose, CA
NPI
1043813132
Since 2020
Specialty
Physician Assistant
Code 363A00000X
Group practices
0
Medicare group memberships
Hospitals
0
Hospital affiliations
2690 S White Rd Ste 50
San Jose, CA, 95148
Phone (408) 223-7000
Medicare paid
-
No Medicare services published
Medicare patients
-
Drug cost, 2024
$3.3M
5,923 prescriptions
Company payments, 2025
$3,590
From 29 companies
Medicare prescription drug claims, 2024
In 2024, the drug Alex Pham prescribed most often to Medicare patients was Jardiance (Empagliflozin), with 734 prescriptions and refills. In total Alex Pham wrote 5,923 Medicare prescriptions that cost $3.3M.
| Drug |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2021-04-21.
| Claims |
|---|
| 30-day fills |
|---|
| Patients |
|---|
| Cost |
|---|
| Jardiance Empagliflozin | 734 | 1,334 | 183 | $749K |
| Ozempic Semaglutide | 420 | 672 | 98 | $623K |
| Metformin Hcl Generic | 382 | 1,090 | 126 | $3,361 |
| Levothyroxine Sodium Generic | 306 | 826 | 92 | $4,940 |
| Trulicity Dulaglutide | 279 | 421 | 68 | $395K |
| Pioglitazone Hcl Generic | 228 | 656 | 81 | $3,634 |
| Atorvastatin Calcium Generic | 218 | 621 | 74 | $2,444 |
| Nano 2nd Gen Pen Needle Pen Needle, Diabetic | 178 | 457 | 70 | $22K |
| Rybelsus Semaglutide | 168 | 323 | 44 | $293K |
| Lantus Solostar Insulin Glargine,hum.Rec.Anlog | 162 | 438 | 59 | $15K |
| Farxiga Dapagliflozin Propanediol | 150 | 258 | 43 | $141K |
| Humalog Kwikpen U-100 Insulin Lispro | 137 | 252 | 47 | $42K |
| Repaglinide Generic | 133 | 351 | 44 | $7,947 |
| Metformin Hcl Er Metformin Hcl | 129 | 366 | 49 | $1,530 |
| Rosuvastatin Calcium Generic | 118 | 345 | 53 | $1,776 |
Brand drugs: 3,126 claims; generic drugs: 2,362 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Alex Pham $3,590 ($3,590 in general payments such as food, travel and fees) from 29 companies. The largest payer was Novo Nordisk Inc with $506.
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc NVO | 25 | $506 |
| Amgen Inc. AMGN | 27 | $505 |
| Madrigal Pharmaceuticals MDGL | 9 | $358 |
| Lilly USA, LLC LLY | 10 | $202 |
| Abbott Laboratories ABT | 13 | $201 |
| Aurinia Pharma U.S., Inc. AUPH | 8 | $193 |
| Sanofi-Aventis U.S. LLC SNY | 4 | $189 |
| GlaxoSmithKline, LLC. GSK | 12 | $173 |
| Pfizer Inc. PFE | 6 | $164 |
| Ascendis Pharma Endocrinology Inc ASND | 4 | $161 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.